课题基金 / 基金详情

Use Of Adipose Derived Stem Cells For Engineering Of Ligament Tissue

Use Of Adipose Derived Stem Cells For Engineering Of Ligament Tissue
使用脂肪干细胞进行韧带组织工程
批准号:
7681830
负责人:
David McAllister
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2012-03-31
关键词:
Activities of Daily LivingAddressAdipose tissueAdverse effectsAdvocateAllograftingAnimal ModelAnimalsAnterior Cruciate LigamentAreaAttentionAutologousAutologous TransplantationBiochemicalBiologicalBiological ModelsBiomechanicsBioreactorsBloodBone MarrowBone Marrow CellsCadaverCanis familiarisCarbonCartilageCategoriesCattleCell TherapyCellsCharacteristicsChondroitin SulfatesChronicClinicalClinical ResearchCollagenCollagen FiberConnective TissueContractureDataData AnalysesDepositionDevicesDisadvantagedDiseaseDoseEmbryoEngineeringEquipmentEthicsExhibitsExtracellular MatrixExtracellular Matrix Protein GeneExtracellular Matrix ProteinsFailureFamily suidaeFasciaFemaleFiberFibroblast Growth Factor 2FibroblastsFibronectinsFractureFrequenciesFundingGel ChromatographyGene ExpressionGerm CellsGlutaralGoalsGoldGolfGrowthGrowth FactorHIVHarvestHealedHealthcareHepatitis BHepatitis CHumanHydrogelsImmunohistochemistryImplantIn VitroInflammationInflammatory ResponseInjuryInstitutionInvestigationKneeKnee boneKnee jointLactic acidLamininLeftLifeLigamentsLocationMaintenanceMeasurableMeasuresMechanical StimulationMechanicsMedicalMeniscus structure of jointMesenchymal Stem CellsMethodsModificationMonitorMorbidity - disease rateNatural regenerationNecrosisNormal tissue morphologyOperative Surgical ProceduresOutcomeOutcome StudyPainParticulatePathway interactionsPatientsPhasePhenotypePhysical activityPlatelet Factor 4PolymersPolytetrafluoroethylenePrimatesProcessProductionPropertyProsthesisProtein BiosynthesisProteinsProteoglycanQuality of lifeRecurrenceRehabilitation therapyRelative (related person)ReportingResearchResistanceRiskRotator CuffRuptureServicesSheepShoulderSiteSkinSoftballSolutionsSourceSpecimenSportsStagingStaining methodStainsStem cellsStimulusStressStructureSurgeonSynovitisTechniquesTenascinTendinitisTendon structureTestingTimeTimeLineTissue EngineeringTissuesToesUnited StatesUnited States Food and Drug AdministrationUnited States National Institutes of HealthVeteransWalkingXenograft procedureabstractingadult stem cellanterior cruciate ligament reconstructionanterior cruciate ligament rupturearticular cartilagebasebonecaprolactonecarbon fibercohortcopolymerdacrondata acquisitiondecorindesign and constructiondisease transmissiongraft failurehamstringhealinghuman TGFB1 proteinhuman adult stem cellimplantationimprovedin vivoinjuredligament injurymeetingsnovelnovel strategiespatient populationpoly(lactic acid)preventprogenitorprogramsprotein expressionpublic health relevancequadriceps musclereconstructionrepairedresearch studyresponsescaffoldstem cell populationsuccesstransmission processtwo-dimensional

项目摘要

项目成果

David McAllister的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Abstract: Rupture of the anterior cruciate ligament (ACL) is one of most common ligament injuries of the knee and is often seen in the VA patient population. There are approximately 102,000 cases requiring surgery each year in the United States. The ACL is an important stabilizer of the knee and its integrity is required for many activities of daily living and sporting activities. In many veterans, the ACL is necessary for recreational sporting activities such as golf and softball and in some patients it is necessary for activities of daily living including walking. When injured, its absence leads to knee instability and often necessitates activity modifications in order to avoid symptomatic instability. In addition, there is evidence to suggest the knee joint will deteriorate if left untreated. Thus, the treatment of ACL injuries is aimed at restoring knee stability to prevent the associated complications of recurrent instability with subsequent damage to the menisci and articular cartilage. Current treatments for ACL ruptures require the use of grafts for reconstruction because the injured ACL has little healing capacity. Current graft options include the use of either autografts (tissue obtained from another uninjured part of the knee) or allografts (tissue obtained from a cadaver donor). Because of the inherent disadvantages with the use of these grafts, it would be advantageous to use a tissue- engineered ACL graft substitute. We are currently investigating ways that this could be accomplished in vitro for later implantation in vivo. The overall goal of this project is to develop a method for seeding a synthetic scaffold with autologous cells, cultivating the cell seeded construct under appropriate conditions in vitro and ultimately implanting it for knee ligament reconstruction. This approach could vastly change the treatment of knee ligament injuries and avoids the disadvantages and risks encountered with the current use of autograft and allograft tissue. This project will utilize a novel bioreactor in which polymer scaffolds created with electrospun fibers seeded with human adipose derived stem cells will be subjected to mechanical stimuli and growth factors in vitro as a preliminary step towards generating neoligament tissue which could later be implanted for ligament reconstruction. We hope to eventually engineer strong neoligaments for ACL reconstruction and the added morbidity associated with the use of autografts and allografts could be avoided. In addition, such a tissue engineering approach could potentially shorten the time necessary for rehabilitation following this type of surgery. PUBLIC HEALTH RELEVANCE: Project Narrative Potential Impact on Veterans Health Care: Because knee ligament injuries which require surgical reconstruction are common in the VA patient population, this proposal has the potential to directly influence the lives of veterans and thereby enhance the quality of services provided by the VA. Although current methods for ACL reconstruction are successful at restoring stability to the knee, there are many side effects and risks to surgical reconstruction due primarily to the use of a graft which is needed to rebuild the injured ligament. In fact, many veterans with this injury are denied surgery for this problem and thus must decrease their physical activity level because the risk of morbidity from the graft harvest is not justified and there are not enough allografts currently available for everyone with this problem. At our VA institution alone, over 150 ACL reconstructions have been performed over the last 6 years. Thus, this proposal can improve the management of ACL injuries in veterans. In addition, basic methods of ligament and tendon tissue engineering developed in this study could be directly applied to other common clinical problems in which tendon or ligament tissue is absent or deficient. These problems include shoulder (rotator cuff) and knee (quadriceps and patellar) tendon ruptures, which are also common in the VA patient population. Furthermore, the results of this research could be applied to engineering of other connective tissues including other tendons, fascia, and skin. Thus, this proposal could ultimately result in substantial improvements in the quality of life of veterans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Use Of Adipose Derived Stem Cells For Engineering Of Ligament Tissue
Use Of Adipose Derived Stem Cells For Engineering Of Ligament Tissue
海外基金